A study in npj Parkinson’s Disease identifies variant severity and polygenic background as determinants of Parkinson’s disease penetrance among GBA1 mutation carriers. The findings enhance understanding of genetic risk stratification and may inform personalized prognostic assessments and therapeutic approaches for this neurodegenerative disorder.